U.S. Chemicals Stock News

NasdaqGS:HWBK
NasdaqGS:HWBKBanks

Hawthorn Bancshares (HWBK) Margin Strength And 30.4% Earnings Growth Test Cautious Narratives

Hawthorn Bancshares (HWBK) has just posted another set of quarterly numbers, with Q4 2025 revenue of US$25.4 million, basic EPS of US$0.90, and net income of US$6.2 million setting the tone for its latest update. The company has seen revenue move from US$23.3 million and EPS of US$0.66 in Q4 2024 to US$25.4 million and EPS of US$0.90 in Q4 2025. Trailing twelve month net income reached US$23.8 million and basic EPS came in at US$3.43, giving investors a margin profile that looks more...
NYSE:STZ
NYSE:STZBeverage

Is It Time To Reassess Constellation Brands (STZ) After Recent Share Price Pullback?

Wondering whether Constellation Brands at around US$156.58 is starting to offer value, or if the recent price still overstates what you are getting. The stock is up 4.4% over the last 30 days and 10.9% year to date, but sits 13.3% lower over 1 year and 25.1% lower over 3 years. This can change how the market views both its growth potential and risk. Recent news coverage has focused on Constellation Brands as a key player in the beverage space, with ongoing attention on how its brand...
NYSE:EIX
NYSE:EIXElectric Utilities

Edison International Wildfire Payouts Reframe Risk And Value Story For Investors

Southern California Edison, a unit of Edison International (NYSE:EIX), has offered more than $500 million in compensation to victims of the Eaton Fire. The payments are being provided through the utility's Wildfire Recovery Compensation Program as an alternative to traditional litigation. The program has begun distributing funds to thousands of claimants within its first six months of operation. Edison International, through Southern California Edison, operates as a regulated electric...
NYSE:HGV
NYSE:HGVHospitality

Hilton Grand Vacations (HGV) Margin Gains And 72.3% EPS Growth Test Lofty 47.2x P/E

Hilton Grand Vacations (HGV) has just opened Q1 2026, with investors watching how its recent run of results, including Q4 2025 revenue of US$1.2b and basic EPS of US$0.56, lines up with the broader story of modest revenue growth and faster earnings progress. Over the past few quarters, the company has seen revenue move from US$1,015m in Q1 2025 to US$1,192m in Q4 2025, while basic EPS shifted from a loss of US$0.18 in Q1 2025 to a profit of US$0.56 by year end. This has set the stage for...
NasdaqGS:ZBRA
NasdaqGS:ZBRAElectronic

Zebra Taps Cubic Vocality And Apera AI For Workflow Growth

Zebra Technologies (NasdaqGS:ZBRA) has formed an alliance with Cubic Vocality to connect conventional two-way radios with Zebra Workcloud Sync software for frontline workers. The company has also made an investment in Apera AI to support robotic automation in manufacturing and logistics operations. Zebra Technologies focuses on devices and software that track assets, data and workers across retail, manufacturing and warehouse settings. The new communications alliance and the move into...
NYSE:ITW
NYSE:ITWMachinery

Illinois Tool Works (ITW) Margin Compression Challenges Earnings Growth Narrative Ahead Of Q1 2026

Illinois Tool Works (ITW) has kicked off its latest reporting cycle with investors focused on how its recent revenue and EPS trends compare with a period of steady, if measured, growth expectations. Over the last few quarters, revenue has moved from US$3,839 million in Q1 2025 to US$4,093 million in Q4 2025, while quarterly basic EPS ranged between US$2.38 and US$2.82. This sets the backdrop for a trailing twelve month picture that pairs multi year earnings growth with a net profit margin of...
NasdaqGS:DRS
NasdaqGS:DRSAerospace & Defense

Is Leonardo DRS (DRS) Still Fairly Priced After Recent Share Price Pullback?

If you are wondering whether Leonardo DRS at around US$40.63 still offers value, it helps to step back and look past the headline share price to what the underlying numbers suggest. The stock has had a mixed run recently, with a 1.9% decline over the last week and an 8.7% decline over the last month, yet it still shows a 16.8% gain year to date and a 1.9% return over the past year. Recent coverage has focused on Leonardo DRS as an Aerospace & Defense name in the context of sector wide...
NYSE:DAR
NYSE:DARFood

Darling Ingredients (DAR) Net Margin Squeeze Challenges Bullish Earnings Narratives

Darling Ingredients (DAR) opened Q1 2026 on the back of a steady run in 2025, with Q4 revenue of US$1.7b, basic EPS of US$0.36 and net income of US$56.9m setting the tone for how investors are reading the latest numbers against a market price of US$64.23. Over the last six reported quarters, the company has seen revenue move from US$1.4b in Q4 2024 to US$1.7b in Q4 2025. Quarterly basic EPS has ranged from a loss of US$0.16 in Q1 2025 to US$0.64 in Q4 2024, so the current release sits within...
NasdaqGM:ESCA
NasdaqGM:ESCALeisure

Escalade (ESCA) Margin Resilience Challenges Long Term Earnings Decline Narrative

Escalade (ESCA) has just put fresh numbers on the table, with recent quarters showing revenue between US$54.3 million and US$67.8 million and basic EPS ranging from roughly US$0.13 to US$0.41 per quarter. This sets the stage for a closer read on how the business is trending into Q1 2026. The company has seen revenue move from US$63.9 million in Q4 2024 to US$62.6 million in Q4 2025, while quarterly basic EPS over that stretch has shifted from US$0.20 to US$0.27 as part of a trailing twelve...
NYSE:GKOS
NYSE:GKOSMedical Equipment

Glaukos (GKOS) Q1 Loss Of US$0.34 EPS Reinforces Bearish Profitability Narrative

Glaukos (GKOS) has opened Q1 2026 with revenue of US$150.6 million and a basic EPS loss of US$0.34, while trailing twelve month revenue sits at US$551.3 million against a net loss of US$189.3 million. Over the past five reported quarters, revenue has moved from US$106.7 million in Q1 2025 to US$150.6 million in Q1 2026, as quarterly EPS losses ranged between US$0.28 and US$2.32. This keeps the spotlight firmly on how quickly the business can turn top line momentum into healthier margins. See...
NasdaqGS:SFM
NasdaqGS:SFMConsumer Retailing

Sprouts Farmers Market (SFM) Q1 EPS Strength Tests Bullish Earnings Growth Narrative

Sprouts Farmers Market (SFM) opened Q1 2026 with revenue of US$2.3b and basic EPS of US$1.73, giving investors a clear look at how the grocer is converting top line into per share profits. Over the last few quarters, revenue has moved from US$2.0b in Q4 2024 to US$2.2b in Q1 2025 and now US$2.3b in Q1 2026, while basic EPS has ranged from US$0.80 to US$1.83 across that stretch. With trailing 12 month EPS at US$5.24 and net income of US$507.4m, the latest print highlights how consistently the...
NYSE:EAT
NYSE:EATHospitality

Is Brinker International (EAT) Still Attractive After Strong Five-Year Share Price Performance?

If you are wondering whether Brinker International at around US$152 per share offers solid value or is pricing in too much optimism, you are not alone. The stock shows returns of 5.8% over 7 days, 6.6% over 30 days, 0.5% year to date and 17.1% over 1 year, with a very large 3 year gain and a 139.9% return over 5 years that many long term holders will be watching closely. Recent coverage has focused on how Brinker International is positioned within the Hospitality sector and what current...
NYSE:MGY
NYSE:MGYOil and Gas

A Look At Magnolia Oil & Gas (MGY) Valuation After Recent Share Price Consolidation

Why Magnolia Oil & Gas is on investors’ radar today Magnolia Oil & Gas (MGY) continues to draw attention after recent share price moves, with the stock flat over the past day but showing mixed returns over the past week and month. For investors tracking energy producers, the company’s recent performance and current valuation metrics offer a fresh reference point when weighing Magnolia against other US exploration and production names. See our latest analysis for Magnolia Oil & Gas. That...
NYSE:HNGE
NYSE:HNGEHealthcare

Is It Time To Reconsider Hinge Health (HNGE) After Recent Digital Care Headlines?

If you are wondering whether Hinge Health at around US$44.60 is priced for opportunity or already reflects high expectations, the next sections will walk through what the current share price may be implying. The stock has recently shown mixed momentum, with a 3.1% move over the last 7 days, a 15.7% change over 30 days, and a year to date return of a 2.1% decline. Recent headlines have focused on Hinge Health's role in digital musculoskeletal care and its position within the broader...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

NovoCure (NVCR) Earnings Story Centers On 20.6% Revenue Growth Versus Ongoing Losses

NovoCure (NVCR) opened 2026 with Q1 results that follow a year where quarterly revenue ranged from about US$155 million to US$174 million and basic EPS stayed in loss-making territory between US$0.22 and US$0.36 per share. Over that stretch, revenue moved from US$161.3 million in Q4 2024 to US$174.4 million in Q4 2025, while quarterly net losses shifted between roughly US$24.5 million and US$65.9 million. This kept margins under pressure but gave investors a clear read on how top line growth...
NYSE:VMC
NYSE:VMCBasic Materials

Vulcan Materials (VMC) TTM Margin Expansion Tests Bullish Profitability Narratives

Vulcan Materials (VMC) opened 2026 with Q1 revenue of US$1.8b and basic EPS of US$1.27, supported by trailing twelve month revenue of US$8.1b and EPS of US$8.50 that frame the latest quarter in a broader earnings run rate. Over recent periods, the company has seen quarterly revenue move between US$1.6b and US$2.3b while EPS has ranged from US$0.98 to US$2.85, giving investors a clear view of how current figures sit within its recent history. With net income holding in the hundreds of millions...
NYSE:AWK
NYSE:AWKWater Utilities

American Water Works Company Q1 Margin Compression Challenges Bullish Profitability Narratives

American Water Works Company (AWK) opened 2026 with Q1 revenue of US$1.2 billion and basic EPS of US$1.01, setting the tone against a trailing twelve month EPS of US$5.65 on revenue of US$5.2 billion. Over the past year the company has seen quarterly revenue move from US$1.14 billion in Q1 2025 to US$1.21 billion in Q1 2026, while basic EPS shifted from US$1.05 to US$1.01, giving investors a clear view of steady top line performance alongside more contained earnings. With net income holding...
NYSE:TBBB
NYSE:TBBBConsumer Retailing

Is It Time To Reassess BBB Foods (TBBB) After Its 21% One Year Share Price Gain?

If you are wondering whether BBB Foods at around US$36.50 is a fair deal or starting to look expensive, this article breaks down what the current price could imply about the stock's value. The share price has seen a 2.1% decline over the last 7 days, a 3.2% gain over the past 30 days and a 6.2% return year to date, while the 1 year return sits at 21.1%. Recent coverage around BBB Foods has focused on its positioning within consumer retailing and how investors are weighing that against its...
NasdaqGS:ILPT
NasdaqGS:ILPTIndustrial REITs

Industrial Logistics Properties Trust (ILPT) Trailing FFO Of US$52.8 Million Tests Bearish Narratives

Industrial Logistics Properties Trust (ILPT) opened 2026 with Q1 reporting framed by recent figures that show total revenue at US$113.9 million in Q4 2025 and basic EPS at a loss of US$0.03 per share, while funds from operations reached US$17.9 million, or US$0.27 per share. Over the past few quarters, revenue has sat in a tight band between US$108.9 million and US$113.9 million, as EPS losses moved from US$0.38 in Q3 2024 to US$0.03 in Q4 2025 and trailing twelve month EPS registered at a...
NYSE:EFX
NYSE:EFXProfessional Services

Equifax Ataeva Credit Tools Launch Raises Questions On Undervalued Shares

Equifax (NYSE:EFX) and Ataeva have announced a new partnership to launch a diagnostic product suite for credit portfolio optimization. The new tools, Ataeva TAPS and Ataeva CYM, use Equifax credit data and proprietary attributes to help financial institutions identify high-value customers and assess portfolio profitability. The product suite is designed for banks and credit unions seeking more detailed insights into consumer credit behavior and market share opportunities. For readers...
NYSE:TT
NYSE:TTBuilding

Trane Technologies (TT) Margin Gain To 13.9% Tests Bearish Profitability Narratives

Trane Technologies (TT) opened Q1 2026 with Q4 2025 revenue of US$5.1b and basic EPS of US$2.74, setting the tone off the latest reported numbers as investors assess how the story is evolving. The company has seen quarterly revenue move from US$4.9b in Q4 2024 to US$5.1b in Q4 2025, while basic EPS shifted from US$2.67 to US$2.74 over the same period, with trailing twelve month EPS at US$13.25 on revenue of US$21.3b. With net profit margins higher over the last year, the setup for this...
NYSE:BDC
NYSE:BDCElectronic

Belden (BDC) Margin Expansion Strengthens Bullish Narratives Ahead Of Q1 2026 Earnings

Belden (BDC) has just put fresh numbers on the board for Q1 2026, coming off a Q4 2025 where revenue was US$720.1 million and basic EPS was US$1.73, supported by trailing twelve month EPS of US$6.00 on revenue of US$2.7 billion. Over the last few reported quarters, the company has seen revenue move from US$666.0 million in Q4 2024 to US$624.9 million in Q1 2025, then to US$671.9 million in Q2 2025 and US$698.2 million in Q3 2025, with EPS ranging between US$1.29 and US$1.73 over that stretch,...
NasdaqGS:ALNY
NasdaqGS:ALNYBiotechs

Alnylam Pharmaceuticals (ALNY) Earnings Turn To Profitability Challenges Premium P/E Narrative

Alnylam Pharmaceuticals (ALNY) opened 2026 on the back of a strong finish to last year, with Q4 2025 revenue of US$1.1b and basic EPS of US$1.41 supported by net income of US$186.4m as the company reported its latest numbers. Over the past few quarters, revenue has moved from US$593.2m in Q4 2024 to US$594.2m in Q1 2025, then to US$773.7m in Q2 2025 and US$1.25b in Q3 2025. Basic EPS shifted from a loss of US$0.65 in Q4 2024 to US$1.91 in Q3 2025 and US$1.41 in Q4 2025, reflecting a clear...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly (LLY) Net Margin At 31.7% Tests Justification For 40.5x P/E Narrative

Eli Lilly (LLY) just followed up a strong 2025 with Q1 2026 results that sit on top of full year revenue of US$65.2b and basic EPS of US$23.00 for the trailing twelve months, underpinned by net income of US$20.6b. Over recent quarters the company has seen revenue move from US$13.5b in Q4 2024 to US$19.3b in Q4 2025, while quarterly basic EPS shifted from US$4.88 to US$7.39. This gives a clear sense of the scale at which earnings are now being generated as margins tighten the focus on...